WeVote
Log In

Bill

Bill

AB 1460

Prescription drug pricing.

2025-2026 Regular Session Introduced by Juan Carrillo and 3 co-sponsors

California bill AB 1460 aims to regulate prescription drug pricing to improve medication affordability for state residents, currently under committee review with pending amendments.

In committee: Hearing postponed by committee.
#prescriptiondrugpricing
0
WeVote Research Nonpartisan
Bill Summary · AB 1460

Legislative bill overview

AB 1460 is a California bill addressing prescription drug pricing, currently under consideration in the Health Committee. The bill has undergone amendments and multiple hearing postponements since its May 2025 referral, suggesting ongoing negotiations between sponsors and committee leadership.

Why is this important

Prescription drug costs significantly impact California residents' healthcare affordability and access to medications. Policy changes in California often influence drug pricing approaches nationally, given the state's large population and market influence.

Potential points of contention

  • Scope of price controls vs. market dynamics: Disagreement over how aggressively to regulate drug pricing without discouraging pharmaceutical innovation or affecting drug availability
  • Implementation mechanisms: Debate over whether pricing reforms should apply to all drugs, specific categories, or only state-funded programs, and enforcement complexity
  • Stakeholder interests: Conflicting priorities among pharmaceutical manufacturers, insurance companies, healthcare providers, patient advocacy groups, and state budget concerns

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.